Integer Holdings ($ITGR) Electrophysiology Demand Slowdown and Sales Guidance Cut Case

S.D. New York

Court

1:25-cv-10251

Case number

07/25/2025

Class period Start

10/22/2025

Class period End

02/09/2026

Lead Plaintiff motion deadline

$ITGR investors filed a claim against Integer Holdings Corporation for overstating demand for its electrophysiology (EP) products, misleading sales guidance, and failing to disclose weakening adoption trends.
After cutting its 2025 sales outlook and warning of continued product demand headwinds into 2026, $ITGR dropped 32.3%, falling from October 22 to October 23, 2025.
$ITGR investors can join this case to be notified about potential recovery.
Case Details:

Between July 25, 2024, and October 22, 2025, Integer repeatedly emphasized its strong positioning in the electrophysiology (EP) device market, which it identified as a major growth driver. Management touted above-market sales growth in its Cardio &amp; Vascular (C&amp;V) segment, citing demand visibility, successful product launches, and customer adoption across high-growth areas like pulse field ablation (PFA). In multiple earnings calls, executives claimed that Integer’s EP business was outperforming peers and would continue to accelerate.

In reality, Integer was experiencing slowing demand for at least two key EP products, which was already impacting sales growth before disclosures were made. Despite this, Integer reaffirmed guidance throughout 2024 and mid-2025, giving investors a misleading impression of stability and growth. While the company acknowledged non-linear customer demand and order patterns, it continued to promote a narrative of sustained momentum in its C&amp;V and EP portfolios.

On October 23, 2025, Integer lowered its full-year 2025 sales guidance and revealed that market adoption for two EP devices was slower than forecasted. The company warned this trend would likely continue into the first half of 2026. Analysts reacted sharply, with Wells Fargo stating that the revised guidance was “materially below the Street,” and downgraded the stock. $ITGR fell over 32% in a single day, closing at $73.89.

Based on these events, $ITGR investors filed a claim against Integer Holdings, alleging the company:
It misrepresented its market position and growth trajectory in the EP device market.
It provided misleading sales forecasts despite internal knowledge of softening demand.
It artificially inflated its stock price by concealing adverse product adoption trends.
Investors argue Integer misled the market about the strength of its electrophysiology product line and future revenue outlook, resulting in significant losses when the truth emerged.

Case Type

US Securities Class Action

Case Status

Lead Plaintiff Appointment

Alleged Offence

Misleading Statements,

Financial Misrepresentation

Suspected Party

Directors,

Management

Security Type

Stocks

Trade Direction

Long

Shock Event Date

10/23/2025

Filing date

12/10/2025

Lead Plaintiff Deadline

02/09/2026

Trusted by industry leaders

Endorsed by top professionals who trust our innovative solutions to drive impactful results.